Beone Medicines LTD. (BEIGF) SEC Filings — 2025
18 SEC filings for Beone Medicines LTD. (BEIGF) in 2025.
Filings
- Beone Medicines LTD. 8-K Filing — 8-K · Dec 19, 2025
- Beone Medicines LTD. 8-K Filing — 8-K · Dec 18, 2025
- BeOne Medicines Ltd. Enters Material Definitive Agreement — 8-K · Nov 19, 2025
- BeOne Medicines Swings to Profit on Robust 41% Revenue Growth — 10-Q · Nov 6, 2025
- BeOne Medicines Ltd. Files 8-K on Financials — 8-K · Aug 29, 2025
- BeOne Medicines Ltd. Enters Material Definitive Agreement — 8-K · Aug 25, 2025
- BeOne Medicines Soars on Strong Q2 Product Sales, Collaboration Growth — 10-Q · Aug 6, 2025
- BeiGene, Ltd. Files 8-K on Security Holder Vote Matters — 8-K · May 21, 2025
- BeiGene Reports Unregistered Equity Sales — 8-K · May 13, 2025
- BeiGene, Ltd. Files Q1 2025 10-Q — 10-Q · May 7, 2025
- BeiGene, Ltd. Files 8-K — 8-K · Apr 29, 2025
- BeiGene, Ltd. Files 8-K on Financials — 8-K · Apr 28, 2025
- BeiGene Files Definitive Proxy Statement — DEF 14A · Apr 7, 2025
- BeiGene Files Proxy Statement for Shareholder Meeting — DEFA14A · Mar 10, 2025
- BeiGene Files 2024 Annual Report Amendment — 10-K/A · Feb 28, 2025
- BeiGene, Ltd. Files 2024 10-K — 10-K · Feb 27, 2025
- BeiGene Files 8-K for Regulatory and Exhibit Disclosures — 8-K · Jan 13, 2025
- BeiGene Files 2023 Annual Report Amendment — 10-K/A · Jan 8, 2025